Article Details
Retrieved on: 2019-03-27 23:56:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Elsewhere, Polyneuron raised CHF 22.5 million ($22.6 million) from Sofinnova Partners and <b>New Enterprise Associates</b> to take an autoimmune drug ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here